Saudi Pharmaceutical Industries and Medical Appliances Corp. (2070) is listed on Tadawul of the Saudi Exchange (Tadawul) under sector Pharma, Biotech & Life Science. Financial data sourced from CMA-mandated XBRL filings via Sahm Screener (sahmscreener.com).

For fiscal year 2024, Saudi Pharmaceutical Industries and Medical Appliances Corp. reported revenue of SAR 1.68B, net profit of SAR 32M, and earnings per share of SAR 0.21. Total assets stood at SAR 4.32B with total equity of SAR 1.38B and total liabilities of SAR 2.79B.

Operating cash flow for 2024 was SAR -331M, representing a cash conversion ratio of -10.39 relative to net profit. Free cash flow was SAR -424M.

Earnings quality analysis by Sahm Screener: Of every SAR 1.00 in reported net profit for 2024, SAR -10.39 arrived as operating cash. This indicates Low quality earnings based on the cash conversion ratio of -10.39.

Revenue growth from 2023 to 2024: +1.8%. Net profit growth over the same period: +450.8%. 3-year revenue CAGR: 26.1%.

Key financial ratios for 2024: Return on Equity 2.3%, Return on Assets 0.7%, Net Margin 1.9%, Debt to Equity 2.02.

In 2023, Saudi Pharmaceutical Industries and Medical Appliances Corp. reported revenue of SAR 1.65B and net profit of SAR -9M, compared to SAR 1.68B and SAR 32M respectively in 2024.